FSL-1 TP2035
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
TLR2/6 agonist (also a putative TLR10 ligand). Activates NF-_B. Induces pro-inflammatory cytokines including IL-8, IL-1_, CCL20 and TNF-_ in vitro. Synergizes with IFN_ to induce CXCL10 release from melanoma cells.
CAS nr:
322455-70-9
Purity:
98%
Molecular Weight:
1666,16
SMILES:
Formula:
C84H140N14O18S
Pathway:
Target:
